SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $70,000 | -23.1% | 15,000 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $91,000 | +106.8% | 15,000 | +87.5% | 0.00% | 0.0% |
Q3 2016 | $44,000 | -67.9% | 8,000 | -51.5% | 0.00% | -66.7% |
Q2 2015 | $137,000 | +136.2% | 16,500 | +32.0% | 0.00% | +200.0% |
Q1 2015 | $58,000 | – | 12,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |